ClinicalTrials.Veeva

Menu

The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes (dOCT-pBCC)

V

Vejle Hospital

Status

Enrolling

Conditions

BCC
Skin Diseases
BCC - Basal Cell Carcinoma
Eyelid Diseases
Eyelid Tumor

Study type

Observational

Funder types

Other

Identifiers

NCT06279143
dOCT-pBCC

Details and patient eligibility

About

The purpose is to investigate the diagnostic value (sensitivity and specificity) of dermal-Optical Coherence Tomography (D-OCT, VivoSight Dx), in patients with clinically suspected BCC lesions inside the periocular region and compare these results to previous reports using D-OCT in diagnosing lesions outside the periocular area.

The Hypotheses:

  • The sensitivity and specificity of D-OCT in diagnosing BCC inside the periocular region is comparable to previous reports on BCC lesions outside the periocular region when the standard D-OCT probe is used.
  • The sensitivity and specificity of D-OCT in diagnosing BCC inside the periocular region is increased when the customised D-OCT probe is used.
  • The sensitivity and specificity of D-OCT in diagnosing periocular BCC is comparable to punch biopsy when both standard and the customised D-OCT probes are used.
  • D-OCT with the 10 and 20-millimeter standoff is capable of subtyping periocular BCC.
  • The inter-observer variation in diagnosing and sub-typing periocular BCC decreases with increasing experience in the scanning procedure.
  • The number of scans to correctly interpret D-OCT decreases with increasing experience in the scanning procedure.
  • Delineation of periocular BCC tumour extension is possible using both D-OCT probes

Enrollment

210 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinically suspected periocular BCC.
  • Biopsy-verified BCC
  • Clinically suspected relapse of periocular BCC
  • Age more than 18 years at baseline.
  • Legally competent, able to give verbal and written consent
  • Communicate in Danish verbally as well as in writing
  • Willingness to participate and able to give informed consent and can comply with protocol requirements.

Exclusion criteria

  • Anatomical circumstances that make OCT-scanning impossible, i.e., extensive scarring of eyelids, or large ulcerating crusts that hampers scanning
  • Unwillingness to undergo a skin biopsy or excision of lesion.
  • Inability to sign informed consent.

Trial contacts and locations

1

Loading...

Central trial contact

Flemming Møller, Assoc.prof.; Sveina B Karlsdóttir, Ph.D.Student

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems